Navigation Links
CMC Biologics Announces Appointment of New CEO
Date:5/2/2011

COPENHAGEN, Denmark and SEATTLE, May 2, 2011 /PRNewswire/ -- CMC Biologics, a leading biopharmaceutical Contract Manufacturing Organization, with operations in Copenhagen, Denmark and Seattle, Washington USA, announced today that it has hired Claes Glassell to serve at its Chief Executive Officer. CMC Biologics, a company with 370 employees, is committed to delivering  world class, fully integrated, biopharmaceutical process development and manufacturing services.

(Logo:  http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

Claes Glassell brings more than 30 years of industry experience to CMC, most recently as CEO of Cerus Corporation and prior to that as President of Cambrex Corp.

"We are thrilled that Claes has joined the CMC executive team," said David Kauffmann, Chairman of the Board, CMC Biologics, and Managing Director of European Equity Partners. "Claes has been on CMC's board of directors for more than 5 years, and has during that time exhibited a broad range of experience and insight of our industry. Claes' strong leadership qualities and seasoned business understanding makes him the ideal leader to take CMC Biologics to the next level as a leader in our fast moving industry."

"Joining the CMC Executive team at this important time in the Company's lifecycle is a great privilege," said Claes Glassell. "The Company has, despite a very challenging environment in recent years, been successful in continuing to realize strong growth. Today, CMC has a very solid order book demonstrating the strength of the Company's world class service offering, management and science team. CMC is positioned to be a highly successful company."

Claes Glassell joined the CMC board of directors in 2005. Claes left the position as President & CEO of Cerus Corporation, Inc. to take on the position as CEO of CMC Biologics. He is the former President of Cambrex Cor
'/>"/>

SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease
2. Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration
3. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities, Trauma, and General Orthopaedics Market with Legato™ Bone Void Filler
4. DSM Biologics Reports a New Record Achievement with DSMs Proprietary XD® Process Technology with a CHO Cell Line Producing an Fc-fusion Protein:
5. MiMedx Completes Acquisition of Surgical Biologics
6. Avaxia Biologics, Inc. to Present Key Pre-Clinical Inflammatory Bowel Disease Remission Data at Biotech Showcase 2011
7. MiMedx Announces Agreement to Acquire Surgical Biologics
8. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
9. Reportlinker Adds Global Biosimilars (Follow-on biologics) Market: An Analysis
10. EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) for Treatment of Acute Lymphoblastic Leukemia
11. Reportlinker Adds Quality for Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 An experimental drug designed to ... viable first treatment for anemia of inflammation, according to results ... published online today in Blood , the ...   Anemia is a condition that occurs when ... function properly. When an individual has anemia, the body does ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces ... is available in its catalogue: ... and Approval of Imported Medical Device ... Edition) http://www.reportlinker.com/p02342770/-Latest-Chinese-Guidebook-for-Application-and-Approval-of-Imported-Medical-Device-Registration-From-Regulations-to-Practices--2014-Edition ... Chinese regulations on medical devices are ...
(Date:8/27/2014)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... clinical trial manufacturing, and advanced analytical and consulting services ... participate at the upcoming Rodman & Renshaw 16 th ... New York . The Company will ... 2014 at the New York Palace Hotel. ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... presentation on strategic collaboration opportunities with SRI,s ... a nonprofit pharmaceutical organization and have the ... development capabilities – from "Idea to IND"®. ... preclinical phases of basic research, drug discovery, ...
... 15, 2010 A combination of two devices ... arrest patients each year if implemented nationwide, suggests ... American Heart Association Resuscitation Science Symposium. A significantly ... arrest survived after receiving active compression decompression cardiopulmonary ...
Cached Medicine Technology:SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010 2SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010 3NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices 2NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices 3
(Date:8/27/2014)... 27, 2014 The extensive polling ... by healthcare research group Black Book Rankings uncovers ... adequately staffed, supplied or built to care for ... initiated this annual survey to gain stakeholder insight ... control, epidemiology and emergency preparedness systems,” said Doug ...
(Date:8/27/2014)... WEDNESDAY, Aug. 27, 2014 (HealthDay News) -- Pouring half a glass ... much, according to a new study. Researchers asked 74 college ... settings and from bottles that had varying amounts of wine in ... normal. Those who had a "rule of thumb" about how ... glass or two fingers from the top -- poured less wine ...
(Date:8/27/2014)... 27, 2014 Connor Sports has ... World Cup in Spain at the Barcelona, Bilbao, Gran ... FIBA Equipment & Venue Centre Partner since 1994 and Official ... six courts will bear the Connor Sports logo and tagline ... globe on the ESPN broadcasts of the FIBA World Cup. ...
(Date:8/27/2014)... TX (PRWEB) August 27, 2014 Picture, if ... not Holmes and Watson but more of a Mr. Inside, ... Davis, in terms of personalities and world view. This Mr. ... University of Texas at Austin, and Mr. Outside was an ... family physician, his new girlfriend, and a gaggle of teenagers ...
(Date:8/27/2014)... NC. SonaCare Medical, LLC, the global ... sales of 15 HIFU devices over the past twelve ... for the company’s ablation technology. , “It is ... achieved over the past year, especially since we are ... our most active sales period,” says Mike Klein, CEO ...
Breaking Medicine News(10 mins):Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4Health News:'Half a Glass' Rule May Curb Overdrinking 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2
... to treat childhood cholera. ,Researchers in Bangladesh have ... effectively with a single dose // of the antibiotic ... The Lancet., ,Cholera is a major global health ... In the resource-limited countries where cholera occurs, any reduction ...
... issue of JAMA says that heart patients who are ... of medications. ,Heart failure affects more than 5 ... States and is associated with a high death rate, ... to reduce the risk of illness and death from ...
... Professor Alice Sigurdson and Colleagues has reported the dosage ... which increases the risk of thyroid cancer. ... were treated for thyroid cancer during their childhood. The ... risk of developing thyroid cancer and there seems to ...
... elevated to the level of health friends. In the same ... to have benefits for coronary heart disease. ,New research ... effect on heart disease and stroke. A research team in ... that drinking a cup of cocoa can prevent potentially fatal ...
... be less at risk from developing the dreaded disease ... the recent issue of Archives of Neurology. ,In ... the course of a MS-like disease in animals, suggesting ... the postpartum period afterward, both states associated with profound ...
... Risk of bone fracture in postmenopausal women might be reduced ... in the September issue of the journal Archives of Internal ... rate of three to five percent per year for about ... high risk for bone fracture, according to background information in ...
Cached Medicine News:Health News:Heart Patients More At Risk Get Fewer Medicines 2Health News:Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region 2Health News:Cocoa: Doesn’t Taste Like Red Wine But Has Benefits Like It 2Health News:Consumption of Soy May Reduce Risk of Fracture in Postmenopausal Women 2
... Uniflex® Nailing System was to develop a ... the widest possible variety of femoral fractures. ... the system takes full advantage of our ... healing combined with modern materials and biomechanical ...
... Quad 4™ Intramedullary Nailing System was to ... used for the widest possible variety of ... were to minimize the number of implants ... system that could address antegrade or retrograde ...
... latest in the Magnes line of biomagnetometer systems, ... full cortical coverage, provides the highest detector density ... of a wide range of neuronal activity. The ... detector configurations and can be equipped with radial ...
... easy voice access to information on the ... easy and intuitive, enabling you to interact ... With the VoiceBox Voice Information Retrieval Software, ... of subjects and topics and receive up-to-date ...
Medicine Products: